Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 22, Number 7, 2015

Articles

Free Content Meet the Editorial Board:
pp. 781-781(1)
Author: Bremner, John

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Open Access Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
pp. 799-818(20)
Authors: Hausmann, Ralf; Kless, Achim; Schmalzing, Gunther

Favourites:
ADD
Favourites:
ADD

P2X Receptors, Sensory Neurons and Pain
pp. 845-850(6)
Authors: Bele, Tanja; Fabbretti, Elsa

Favourites:
ADD
Favourites:
ADD

P2X Receptors and Inflammation
pp. 866-877(12)
Author: Di Virgilio, Francesco

Favourites:
ADD

Emerging Roles of P2X Receptors in Cancer
pp. 878-890(13)
Authors: Adinolfi, Elena; Capece, Marina; Amoroso, Francesca; De Marchi, Elena; Franceschini, Alessia

Favourites:
ADD

P2X Receptors and Diabetes
pp. 891-901(11)
Authors: Fotino, Carmen; Vergani, Andrea; Fiorina, Paolo; Pileggi, Antonello

Favourites:
ADD

The Role of P2X Receptors in Bone Biology
pp. 902-914(13)
Authors: Jorgensen, N.R.; Syberg, S.; Ellegaard, M.

Favourites:
ADD

Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists
pp. 915-928(14)
Authors: Lambertucci, Catia; Dal Ben, Diego; Buccioni, Michela; Marucci, Gabriella; Thomas, Ajiroghene; Volpini, Rosaria

Favourites:
ADD

Medicinal Chemistry of P2X Receptors: Allosteric Modulators
pp. 929-941(13)
Author: E. Muller, Christa

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content